Stroke
Conditions
Brief summary
* Quantitative assessment method developed for brain plasticity through disability rehabilitation using a brain imaging technique. * Development of brain imaging technology to improve understanding of brain plasticity during rehabilitation and to improve the efficiency of rehabilitation treatment for people with brain injury. ○ Development of the latest brain function image analysis algorithm and data processing technology * Development of new technology for imaging brain plasticity in addition to existing functional imaging technology and diffuse imaging technology (Example: Myelinated brain imaging technology, susceptibility imaging (SWI) technology) * Development of image reconstruction software technology using new image technology * Multi-image and repeated shot data processing technology, wheat analysis technology development (Example: 3D registration technology, automated segmentation technology) * Conducted clinical research on clinical quantitative evaluation of brain plasticity due to rehabilitation treatment * Recruitment of a group of patients for pursuing plasticity through rehabilitation among stroke patients (estimating the number of sample patients by setting a specific patient group and analyzing statistical power) * Image-based brain change analysis through patient rehabilitation and before and after imaging * Comparative analysis through securing a control group and activating the control group. Derivation of clinical relevance through comparison with rehabilitation process
Interventions
DEVICEupper robot Robot assisted upper arm training(RAT)
The training group received an additional upper robot Robot assisted upper arm training(RAT) with Armeopower® 5 times per week for 4weeks. \*Robot Assisted Arm training + Conventional occupational therapy
BEHAVIORALConventional therapy
The control group received the usual conventional therapy \*Only Conventional occupational therapy
Sponsors
Yonsei University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
1. less than 6 months after onset of the stroke 2. have FMA score greater than 7 3. have confirmed that the integrity of the Corticospinal Tract (CST) is preserved in Diffusion Tensor Imaging (DTI) taken using 4. over 20 years of age 5. can understand and participated in study 6. consented to this study in writing or verbally
Exclusion criteria
1. quadriplegia 2. past history of stroke 3. past history of Musculoskeletal disease or history of Neurological diseases 4. have a history of injury to the upper limb and upper chest, surgery, or peripheral nerve damage 5. have skin ulcers or skin diseases such as open wounds that have difficulty applying RAT 6. Pregnant woman 7. If it is judged that this clinical participation is not appropriate according to the judgment of medical doctor
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Fugl-Meyer Assessment (FMA) | before training(0week) | The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia |
Countries
South Korea
Contacts
Primary ContactDeog Young Kim
Outcome results
None listed